Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Not applicableLooking for participantsNCT05878964What this trial is testingEvaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.Who this might be right forLung CancerBreast CancerKidney Cancer+5 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Early research (Phase 1)Study completedNCT03289962What this trial is testingAutogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsWho this might be right forMelanomaNon-Small Cell Lung CancerBladder Cancer+5 more Genentech, Inc. 273
Early research (Phase 1)Looking for participantsNCT06242470What this trial is testingMGC026 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorAdvanced CancerMetastatic Cancer+19 more MacroGenics 250
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72
Early research (Phase 1)Ended earlyNCT03621982What this trial is testingStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsWho this might be right forHead and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more ADC Therapeutics S.A. 78
Not applicableLooking for participantsNCT00001823What this trial is testingEvaluation for NCI Surgery Branch Clinical Research ProtocolsWho this might be right forSynovial Cell CancerMelanomaColorectal Cancer+2 more National Cancer Institute (NCI) 7,000
Early research (Phase 1)UnknownNCT05235607What this trial is testingPersonalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid TumorsWho this might be right forCarcinomaMelanomaBladder Cancer+1 more Sichuan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05267626What this trial is testingStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerWho this might be right forAdvanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT05259696What this trial is testingGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)Who this might be right forOncologyMelanomaOvarian Cancer+14 more Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Ended earlyNCT02554812What this trial is testingAvelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)Who this might be right forAdvanced Cancer Pfizer 409
Not applicableActive Not RecruitingNCT05520099What this trial is testingObservational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)Who this might be right forImmunotherapyCancerBladder Cancer+16 more Elephas 416
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Early research (Phase 1)Ended earlyNCT02576665What this trial is testingToca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)Who this might be right forColorectal CancerTriple Negative Breast CancerPancreatic Cancer+9 more Tocagen Inc. 21
Not applicableUnknownNCT00757614What this trial is testingStudy of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomWho this might be right forBladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more Cancer Research UK 14,000
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07341737What this trial is testingSL-28 for Advanced Solid TumoursWho this might be right forHead & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more Second Life Therapeutics 60
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Early research (Phase 1)UnknownNCT02457650What this trial is testingT Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesWho this might be right forBladder CarcinomaBreast CancerEsophagus Carcinoma+7 more Shenzhen Second People's Hospital 36
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120